Insmed (INSM) Tops Q2 EPS by 5c, Revenues Beat

August 1, 2019 7:54 AM

Insmed (NASDAQ: INSM) reported Q2 EPS of ($0.81), $0.05 better than the analyst estimate of ($0.86). Revenue for the quarter ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found